1996Phase I-II study of high-dose busulfan and cyclophosphamide followed by autologous peripheral blood stem cell transplantation for hematological malignancies: toxicities and hematopoietic recovery.
Bone marrow transplantation.18(1):9-14[DOI] .[PMID] 8831989.